+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats



A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats



Journal of Periodontology 72(8): 1069-1077



Chemically modified non-antimicrobial tetracyclines (CMTs) have been shown to inhibit pathologically elevated collagenase (and other matrix metalloproteinase, MMP) activity and bone resorption in vivo and in vitro. In the current study, suboptimal doses of CMT-8 (a non-antimicrobial chemically modified doxycycline) and a bisphosphonate (clodronate, an anti-bone resorption compound) were administered daily, either as a single agent or as a combination therapy, to rats with experimental periodontitis induced by repeated injection of bacterial endotoxin (LPS) into the gingiva. At the end of the 1-week protocol, the gingival tissues were dissected, extracted, and the extracts analyzed for MMPs (collagenases and gelatinases) and for elastase, and the defleshed jaws were morphometrically analyzed for alveolar bone loss. LPS injection significantly (P<0.001) increased alveolar bone loss and increased collagenase (MMP-8), gelatinase (MMP-9), and elastase activities. Treatment of the LPS-injected rats with suboptimal CMT-8 alone or suboptimal clodronate alone produced slight reductions in the tissue-destructive proteinases and no significant reductions in alveolar bone loss. However, a combination of suboptimal CMT-8 and clodronate "normalized" the pathologically elevated levels of MMPs, elastase, and alveolar bone loss, indicating synergistic inhibition of tissue breakdown in this animal model of periodontitis. Combination of a CMT and a bisphosphonate may be a useful treatment to optimally suppress periodontal destruction and tooth loss and in other tissue-destructive inflammatory diseases such as arthritis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010052941

Download citation: RISBibTeXText

PMID: 11525440

DOI: 10.1902/jop.2001.72.8.1069


Related references

A combination of subtherapeutic doses of chemically modified doxycycline (CMT-8) and a bisphosphonate (clodronate) inhibits bone loss in the ovariectomized rat: a dynamic histomorphometric and gene expression study. Current Medicinal Chemistry 8(3): 295-303, 2001

A Combination of Subtherapeutic Doses of Chemically Modified Doxycycline (Cmt-8) and a Bisphosphonate (Clodronate) Inhibits Bone Loss in the Ovariectomized Rat A Dynamic Histomorphometric and Gene Expression Study. Current Medicinal Chemistry 8(3): 295-303, 2001

A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Annals of the new York Academy of Sciences 878: 290-310, 1999

A chemically modified nonantimicrobial tetracycline inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Greenwald, R A, Zucker, S, Golub, L M Annals of the New York Academy of Sciences; Inhibition of matrix metalloproteinases: Therapeutic applications 290-310, 1999

Tissue healing with doxycycline and chemically modified tetracycline treatments in rats with Porphyromonas gingivalis-induced periodontitis. Annals of the new York Academy of Sciences 732: 433-435, 1994

The expression of collagen I and XII mRNAs in Porphyromonas gingivalis-induced periodontitis in rats: the effect of doxycycline and chemically modified tetracycline. Journal of Periodontology 69(1): 34-40, 1998

Tetrandrine inhibits breakdown of blood-aqueous barrier induced by endotoxin and interleukin-1 alpha in rats. Journal of Ocular Pharmacology and Therapeutics 12(3): 323-329, 1996

A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects. Journal of Periodontal Research 52(2): 186-200, 2017

Wound healing in aged normal and ovariectomized rats Effects of chemically modified doxycycline on MMP expression and collagen synthesis. Greenwald, R A , Zucker, S , Golub, L M Annals of the New York Academy of Sciences; Inhibition of matrix metalloproteinases: Therapeutic applications 720-723, 1999

Wound healing in aged normal and ovariectomized rats: effects of chemically modified doxycycline (CMT-8) on MMP expression and collagen synthesis. Annals of the new York Academy of Sciences 878: 720-723, 1999

CMT-8/clodronate combination therapy synergistically inhibits alveolar bone loss in LPS-induced periodontitis. Annals of the new York Academy of Sciences 878: 671-674, 1999

A novel chemically modified curcumin reduces severity of experimental periodontal disease in rats: initial observations. Mediators of Inflammation 2014: 959471, 2014

Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats. Journal of Periodontology 75(11): 1516-1523, 2004

Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. Journal of Periodontology 73(7): 726-734, 2002

Chemically modified tetracycline inhibits alveolar bone loss in rats. Journal of Dental Research 70(SPEC ISSUE APRIL): 468, 1991